Treatment of age-related macular degeneration: focus on ranibizumab
Martin S Spitzer, Focke Ziemssen, Karl U Bartz-Schmidt, Faik Gelisken, Peter SzurmanTuebingen University Eye Center, University of Tuebingen, GermanyAbstract: Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms of VEGF-A ...
Martin S Spitzer +4 more
core
Early Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in France: A Retrospective Study. [PDF]
Fricker J +13 more
europepmc +1 more source
Faricimab in neovascular age-related macular degeneration: aqueous humor cytokine profiling and biomarker correlations. [PDF]
Wan Z +6 more
europepmc +1 more source
Real-world outcomes of faricimab in treatment-naïve patients with neovascular age-related macular degeneration. [PDF]
Chang W, Kim J, Jeon J, Park S.
europepmc +1 more source
Clinical Value of Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration. [PDF]
Asanad S, Thomspon J.
europepmc +1 more source
Recent developments in age-related macular degeneration: a review
Waseem M Al-Zamil, Sanaa A Yassin Department of Ophthalmology, Imam Abdulrahman Bin Faisal University, Al-Khobar, Saudi Arabia Background: Visual impairment in elderly people is a considerable health problem that significantly affects quality of life ...
Yassin SA, Al-Zamil WM
core
Non neovascular Age - related macular degeneration - Review on clinical and imaging advances. [PDF]
Savastano MC +7 more
europepmc +1 more source
Association of Vortex Vein Morphology with Punctate Hyperfluorescence on ICGA in Neovascular Age-Related Macular Degeneration. [PDF]
Kamao H +5 more
europepmc +1 more source
Correction: Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis. [PDF]
Sun G +12 more
europepmc +1 more source
Evaluation of serum semaphorin-3A and interleukin 6 levels in patients with neovascular age-related macular degeneration. [PDF]
Okutucu M, Arpa M.
europepmc +1 more source

